High Dietary Iron Supplement Induces the Nigrostriatal Dopaminergic Neurons Lesion in Transgenic Mice Expressing Mutant A53T Human Alpha-Synuclein

High Dietary Iron Supplement Induces the Nigrostriatal Dopaminergic Neurons Lesion in Transgenic Mice Expressing Mutant A53T Human Alpha-Synuclein

Both alpha-synuclein aggregation and iron deposits are neuropathological hallmarks of Parkinson’s disease (PD). We are particularly interested in whether iron could synergize with alpha-synuclein pathology in vivo, especially in the nigrostriatal system. In the present study, we reported transgenic...

Full description

Bibliographic Details
Main Authors:	Fengju Jia, Ning Song, Weiwei Wang, Xixun Du, Yajing Chi, Hong Jiang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-04-01
Series:	Frontiers in Aging Neuroscience
Subjects:	iron alpha-synuclein substantia nigra Parkinson’s disease aging
Online Access:	http://journal.frontiersin.org/article/10.3389/fnagi.2018.00097/full

Similar Items

The Nigral Coup in Parkinson’s Disease by α-Synuclein and Its Associated Rebels
by: Jeswinder Sian-Hulsmann, et al.
Published: (2021-03-01)

Age and α-synuclein expression interact to reveal a dependence of dopaminergic axons on endogenous Akt/PKB signaling
by: Sang Ryong Kim, et al.
Published: (2011-11-01)

Reduced complement of dopaminergic neurons in the substantia nigra pars compacta of mice with a constitutive “low footprint” genetic knockout of alpha-synuclein
by: Valeria V. Goloborshcheva, et al.
Published: (2020-05-01)

Specific immune modulation of experimental colitis drives enteric alpha-synuclein accumulation and triggers age-related Parkinson-like brain pathology
by: Stefan Grathwohl, et al.
Published: (2021-05-01)

Abnormal alpha-synuclein reduces nigral voltage-dependent anion channel 1 in sporadic and experimental Parkinson's disease
by: Yaping Chu, et al.
Published: (2014-09-01)

α-Synuclein expression in the substantia nigra of MPTP-lesioned non-human primates
by: Maya G. Purisai, et al.
Published: (2005-12-01)

14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model
by: Rachel Underwood, et al.
Published: (2021-01-01)

Transcriptional dysregulation in a transgenic model of Parkinson disease
by: Talene A. Yacoubian, et al.
Published: (2008-03-01)

Age-associated increases of α-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
by: Yaping Chu, et al.
Published: (2007-01-01)

Neuroprotective and neurorestorative effects of neuregulins in the injured and aged dopaminergic nigrostriatal system
by: Dickerson, Jonathan W.
Published: (2010)

GDNF and alpha-synuclein in nigrostriatal degeneration
by: Chermenina, Maria
Published: (2014)

α-synuclein aggregation reduces nigral myocyte enhancer Factor-2D in idiopathic and experimental Parkinson's disease
by: Yaping Chu, et al.
Published: (2011-01-01)

MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity
by: Bobby Thomas, et al.
Published: (2007-05-01)

Kinase activity is required for the toxic effects of mutant LRRK2/dardarin
by: Elisa Greggio, et al.
Published: (2006-08-01)

Is alpha-synuclein loss-of-function a contributor to parkinsonian pathology? Evidence from non-human primates
by: Timothy J Collier, et al.
Published: (2016-01-01)

Proteolytic α-Synuclein Cleavage in Health and Disease
by: Alexandra Bluhm, et al.
Published: (2021-05-01)

Parkinson's disease: Cell Vulnerability and Disease Progression
by: Javier eBlesa, et al.
Published: (2015-09-01)

Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils
by: Joseph R. Patterson, et al.
Published: (2019-10-01)

Can Interactions Between α-Synuclein, Dopamine and Calcium Explain Selective Neurodegeneration in Parkinson's Disease?
by: Michael R. Post, et al.
Published: (2018-03-01)

Lesion of the subthalamic nucleus reverses motor deficits but not death of nigrostriatal dopaminergic neurons in a rat 6-hydroxydopamine-lesion model of Parkinson's disease
by: V. Rizelio, et al.
Published: (2010-01-01)

Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant α-synuclein rat model of parkinsonism
by: Jacqueline A. Gleave, et al.
Published: (2017-10-01)

Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: Diminished compensatory mechanisms as a prelude to parkinsonism
by: Timothy J. Collier, et al.
Published: (2007-04-01)

Tau gene transfer, but not alpha-synuclein, induces both progressive dopamine neuron degeneration and rotational behavior in the rat
by: Ronald L. Klein, et al.
Published: (2005-10-01)

Function and Regulation of ALDH1A1-Positive Nigrostriatal Dopaminergic Neurons in Motor Control and Parkinson’s Disease
by: Kathleen Carmichael, et al.
Published: (2021-05-01)

Long Non-coding RNAs Associated With Neurodegeneration-Linked Genes Are Reduced in Parkinson’s Disease Patients
by: Maximilianos Elkouris, et al.
Published: (2019-02-01)

Alpha-synuclein structure, functions, and interactions
by: Fatemeh Nouri Emamzadeh
Published: (2016-01-01)

Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons
by: Franziska Richter, et al.
Published: (2014-09-01)

Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter
by: Amy B. Manning-Boğ, et al.
Published: (2007-08-01)

The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson’s Disease
by: Georgia Minakaki, et al.
Published: (2020-12-01)

Quantification of alpha-synuclein in cerebrospinal fluid
by: Kronander, Björn
Published: (2012)

Evidence for Dysfunction of the Nigrostriatal Pathway in the R6/1 Line of Transgenic Huntington's Disease Mice
by: Å. Petersén, et al.
Published: (2002-10-01)

Epothilone B Benefits Nigral Dopaminergic Neurons by Attenuating Microglia Activation in the 6-Hydroxydopamine Lesion Mouse Model of Parkinson’s Disease
by: Zhongyuan Yu, et al.
Published: (2018-09-01)

Alpha-synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits
by: Penelope J. Hallett, et al.
Published: (2012-08-01)

Cross-talk between mitochondria and proteasome in Parkinson's disease pathogenesis
by: Diogo Martins Branco, et al.
Published: (2010-05-01)

Targeting α-synuclein by PD03 AFFITOPE® and Anle138b rescues neurodegenerative pathology in a model of multiple system atrophy: clinical relevance
by: Miguel Lemos, et al.
Published: (2020-09-01)

Neonatal exposure to lipopolysaccharide enhances vulnerability of nigrostriatal dopaminergic neurons to rotenone neurotoxicity in later life
by: Lir-Wan Fan, et al.
Published: (2011-12-01)

Editorial: The Protein Alpha-Synuclein: Its Normal Role (in Neurons) and Its Role in Disease
by: Ruth G. Perez
Published: (2020-02-01)

Oxidative Stress and Genetics in the Pathogenesis of Parkinson's Disease
by: Yi Zhang, et al.
Published: (2000-08-01)

Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration
by: Maya G. Purisai, et al.
Published: (2007-02-01)

Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration
by: Katrina L. Paumier, et al.
Published: (2015-10-01)